Primary Biotech

Primary(Changzhou) Biotechnology Co., Ltd. is a high-tech company driven by computational innovation in drug development. The company's current goal is to develop innovative algorithms to improve the efficiency of new drug research and development based on cutting-edge technologies such as artificial intelligence, molecular simulation, and cloud computing. The core R&D team consists of returned overseas Ph.D.s with professional backgrounds in applied mathematics, medicinal chemistry, medical genetics, etc., forming a closed-loop R&D process comprising three key components: algorithm development, algorithm application, and experimental validation. This allows for efficient algorithm iteration to address critical issues at different stages of new drug development, providing optimal solutions.